Clinical Approach to Infections in the Compromised Host

Published on 04/03/2015 by admin

Filed under Hematology, Oncology and Palliative Medicine

Last modified 04/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1248 times

Chapter 40 Clinical Approach to Infections in the Compromised Host

Table 40-1 Malignant and Select Nonmalignant Hematologic Diseases and Their Associated Infection-Predisposing Host Defects

Hematologic Condition Infection-Predisposing Host Defects
Acute myeloid leukemia Neutropenia; therapies such as dose-intensive chemotherapy and hematopoietic stem cell transplant may result in additional anatomic disruptions, cell-mediated defects, and humoral defects
Acute lymphocytic leukemia Neutropenia; therapy effects similar to acute myeloid leukemia
Hairy cell leukemia Neutropenia (also monocytopenia); abnormal humoral immunity; T-cell suppressing therapy
Chronic lymphocytic leukemia Hypogammaglobulinemia; abnormal cell-mediated immunity
Chronic myeloid leukemia No prominent host defects unless aggressive therapy, advanced stage, or postsplenectomy
Multiple myeloma Hypogammaglobulinemia; other host defects may occur with aggressive therapy or advanced stage
Hodgkin/non-Hodgkin lymphomas Abnormal cell-mediated immunity, therapy-related neutropenia, splenic dysfunction (if splenectomy or radiation)
Myelodysplastic syndromes Functional or absolute neutropenia
Aplastic anemia Neutropenia; abnormal cell-mediated immunity from immunosuppressive therapies (e.g., steroids, antithymocyte globulin, cyclosporine, hematopoietic stem cell transplantation)
Paroxysmal nocturnal hemoglobinuria Deficient Fc receptor may contribute to abnormal cell-mediated immunity
Hemolytic states (thalassemia) Gallstones may serve as a nidus for infection; splenic dysfunction or splenectomy
Sickle cell disease Can be neutropenic with aplastic crisis; bone infarcts may serve as a nidus for infection; splenic dysfunction with poor complement activation and opsonization from autosplenectomy

Approach to Pulmonary Infiltrates

Buy Membership for Hematology, Oncology and Palliative Medicine Category to continue reading. Learn more here